HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens.

AbstractPURPOSE:
To determine whether implantation of a new intraocular lens (IOL) with a modified prolate anterior surface, designed to reduce the positive spherical aberration of the pseudophakic eyes, results in improved contrast sensitivity assessed in terms of low contrast visual acuity (VA).
METHODS:
We carried out an intraindividual study of 12 patients with bilateral cataracts, randomized to receive a prolate anterior surface IOL (Tecnis Z9000, Pharmacia) in one eye and a biconvex spherical surface IOL (CeeOn 911 A, Pharmacia) in the other. High and low contrast VA was assessed under photopic conditions, before and after pupil dilation.
RESULTS:
After mydriasis, the Technis Z9000 provided significantly better low contrast VA at contrast levels < or = 25%. No significant difference was found under normal pupil conditions.
CONCLUSION:
Our results confirm the hypothesis that the spherical aberration of the eye after cataract surgery can be reduced by an anterior prolate surface IOL.
AuthorsFederico Ricci, Gianluca Scuderi, Filippo Missiroli, Federico Regine, Angelica Cerulli
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 82 Issue 6 Pg. 718-22 (Dec 2004) ISSN: 1395-3907 [Print] Denmark
PMID15606470 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Aged
  • Contrast Sensitivity (physiology)
  • Female
  • Humans
  • Lens Implantation, Intraocular
  • Lenses, Intraocular
  • Male
  • Middle Aged
  • Phacoemulsification
  • Prosthesis Design
  • Pseudophakia (physiopathology)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: